164 related articles for article (PubMed ID: 8390230)
21. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
Lorent N; De Leyn P; Lievens Y; Verbeken E; Nackaerts K; Dooms C; Van Raemdonck D; Anrys B; Vansteenkiste J;
Ann Oncol; 2004 Nov; 15(11):1645-53. PubMed ID: 15520066
[TBL] [Abstract][Full Text] [Related]
22. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
Park JH; Shim YM; Baek HJ; Kim MS; Choe DH; Cho KJ; Lee CT; Zo JI
Ann Thorac Surg; 1999 Nov; 68(5):1821-6. PubMed ID: 10585065
[TBL] [Abstract][Full Text] [Related]
24. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
25. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
[TBL] [Abstract][Full Text] [Related]
26. [Preoperative induction chemotherapy for unresectable stage IIIA non-small-cell lung cancer].
Wang SY; Zeng ZF; Ou W; Lin YB; Rong TH
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):747-9. PubMed ID: 16483489
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.
Chella A; Lucchi M; Ribechini A; Silvano G; Mussi A; Janni A; Angeletti CA
Eur J Surg Oncol; 1995 Aug; 21(4):393-7. PubMed ID: 7664906
[TBL] [Abstract][Full Text] [Related]
28. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
29. A preoperative alternating chemotherapy and radiotherapy program for patients with stage IIIA (N2) non-small cell lung cancer.
Takamori S; Rikimaru T; Hayashi A; Tayama K; Mitsuoka M; Fujimoto K; Horiuchi M; Hayabuchi N; Oizumi K; Shirouzu K
Lung Cancer; 2000 Jul; 29(1):49-56. PubMed ID: 10880847
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin, mitomycin, and vindesine followed by intraoperative and postoperative radiotherapy for stage III non-small cell lung cancer: final results of a phase II study.
Aristu J; Rebollo J; MartÃnez-Monge R; AramendÃa JM; Viera JC; Azinovic I; Herreros J; Brugarolas A
Am J Clin Oncol; 1997 Jun; 20(3):276-81. PubMed ID: 9167753
[TBL] [Abstract][Full Text] [Related]
31. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
32. Preoperative chemotherapy and immunochemotherapy for locally advanced stage IIIA and IIIB non small cell lung cancer. Preliminary results.
Ciriaco P; Rendina EA; Venuta F; De Giacomo T; Della Rocca G; Flaishman I; Baroni C; Cortesi E; Bonsignore G; Ricci C
Eur J Cardiothorac Surg; 1995; 9(6):305-9. PubMed ID: 7546802
[TBL] [Abstract][Full Text] [Related]
33. The case for mitomycin in non-small cell lung cancer.
Spain RC
Oncology; 1993 Apr; 50 Suppl 1():35-50. PubMed ID: 8387177
[TBL] [Abstract][Full Text] [Related]
34. Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).
Riggi M; Ruffie P; Voisin S; Monnet I; de Cremoux H; Saltiel JC; Martin M; Vergne L; Huet J; Cvitkovic E
Eur J Cancer; 1991; 27(10):1238-42. PubMed ID: 1659842
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
[TBL] [Abstract][Full Text] [Related]
36. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
Phernambucq EC; Biesma B; Smit EF; Paul MA; vd Tol A; Schramel FM; Bolhuis RJ; Postmus PE
Br J Cancer; 2006 Aug; 95(4):470-4. PubMed ID: 16909132
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
Arriagada R; Bergman B; Dunant A; Le Chevalier T; Pignon JP; Vansteenkiste J;
N Engl J Med; 2004 Jan; 350(4):351-60. PubMed ID: 14736927
[TBL] [Abstract][Full Text] [Related]
38. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.
Kirn DH; Lynch TJ; Mentzer SJ; Lee TH; Strauss GM; Elias AD; Skarin AT; Sugarbaker DJ
J Thorac Cardiovasc Surg; 1993 Oct; 106(4):696-702. PubMed ID: 8412265
[TBL] [Abstract][Full Text] [Related]
39. [Effect of preoperative chemotherapy for bulky N2 non-small-cell lung cancer].
Togashi K; Sugawara M; Miyamura H; Sato Y; Tanabe Y; Kourakata H; Saito H; Sato K
Kyobu Geka; 1999 Oct; 52(11):915-9. PubMed ID: 10513156
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
Fukuoka M; Masuda N; Furuse K; Negoro S; Takada M; Matsui K; Takifuji N; Kudoh S; Kawahara M; Ogawara M
J Clin Oncol; 1991 Apr; 9(4):606-13. PubMed ID: 1648597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
